Document Detail

5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.
MedLine Citation:
PMID:  1839829     Owner:  NLM     Status:  MEDLINE    
Naftopidil, a novel antihypertensive compound, possesses 5-HT1A agonistic properties in addition to being an alpha 1-adrenoceptor antagonist. The IC50 values for alpha 1-adrenoceptors (235 nmol/l) and for 5-HT1A receptors (108 nmol/l) lie in the same concentration range. The reduction in blood pressure of anesthetized cats by 8-OH-DPAT and urapidil was completely abolished by spiroxatrine, a 5-HT1A antagonist. However, the decreases in blood pressure induced by naftopidil were only partly antagonized by spiroxatrine.
H O Borbe; P Metzenauer; I Szelenyi
Related Documents :
6337029 - Effects of clonidine on sympathetic function.
9728839 - Intrathecal clonidine and fentanyl with hyperbaric bupivacaine improves analgesia durin...
2164099 - Pharmacologic activity of prazosin is decreased by alpha-1-acid glycoprotein in vivo.
7591009 - Suppressing sympathetic activation in congestive heart failure. a new therapeutic strat...
2455169 - Normalization of blood pressure and plasma concentrations of beta-endorphin and leucine...
1783359 - Regional hemodynamic effects of rilmenidine and clonidine in the conscious spontaneousl...
8090539 - Changes induced by nicardipine slow release in forearm and myocardial hemodynamics of s...
23872579 - An autonomic link between inhaled diesel exhaust and impaired cardiac performance: insi...
12003099 - Impact of ambulatory blood pressure monitoring on daily activity.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pharmacology     Volume:  205     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1991 Nov 
Date Detail:
Created Date:  1992-06-09     Completed Date:  1992-06-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  105-7     Citation Subset:  IM    
ASTA Pharma AG, Department of Biochemistry, Frankfurt/Main, F.R.G.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / pharmacology*
Dioxanes / pharmacology
Dopamine Antagonists
Hemodynamics / drug effects
Naphthalenes / pharmacology*
Piperazines / pharmacology*
Radioligand Assay
Rats, Inbred Strains
Receptors, Serotonin / drug effects*
Spiro Compounds / pharmacology
Tetrahydronaphthalenes / metabolism
Reg. No./Substance:
0/Antihypertensive Agents; 0/Dioxanes; 0/Dopamine Antagonists; 0/Naphthalenes; 0/Piperazines; 0/Receptors, Serotonin; 0/Spiro Compounds; 0/Tetrahydronaphthalenes; 1054-88-2/spiroxatrine; 57149-07-2/naftopidil; 78950-78-4/8-Hydroxy-2-(di-n-propylamino)tetralin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nuclear imaging in acute cardiac care.
Next Document:  Effects on isolated arteries from rat, rabbit and man of NNC 70-0270, a synthetic atrial natriuretic...